Nebenwirkungen · Twinrix Adult
Twinrix Adult, suspension for injection in pre-filled syringe Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed). · Abschnitt 4.8 · PDF-Seite 5–6
HOS-085935 · Präparat HOS-083226
5 System Organ Class Frequency Adverse reactions Clinical trials Infections and infestations Uncommon Upper respiratory tract infection Blood and lymphatic system disorders Rare Lymphadenopathy Metabolism and nutrition disorders Rare Decreased appetite Nervous system disorders Very common Headache Uncommon Dizziness Rare Hypoaesthesia, paraesthesia Vascular disorders Rare Hypotension Gastrointestinal disorders Common Gastrointestinal symptoms, diarrhoea, nausea Uncommon Vomiting, abdominal pain* Skin and subcutaneous tissue disorders Rare Rash, pruritus Very rare Urticaria Musculoskeletal and connective tissue Uncommon Myalgia disorders Rare Arthralgia General disorders and administration Very common Pain and redness at the injection site, site conditions fatigue Common Swelling at the injection site, injection site reactions (such as haematoma, pruritus and bruising), malaise Uncommon Fever ( 37.5°C) Rare Influenza like illness, chills Post-marketing surveillance The following adverse reactions have been reported with either Twinrix or with GlaxoSmithKline monovalent hepatitis A or B vaccines: Infections and infestations Meningitis Blood and lymphatic system disorders Thrombocytopenia, thrombocytopenic purpura Immune system disorders Anaphylaxis, allergic reactions including anaphylactoid reactions and mimicking serum sickness Nervous system disorders Encephalitis, encephalopathy, neuritis, neuropathy, paralysis, convulsions Vascular disorders Vasculitis Skin and subcutaneous tissue disorders Angioneurotic oedema, lichen planus, erythema multiforme Musculoskeletal and connective tissue Arthritis, muscular weakness disorders General disorders and administration Immediate injection site pain site conditions Following widespread use of the monovalent hepatitis A and/or hepatitis B vaccines, the following undesirable events have additionally been reported in temporal association with vaccination: Nervous system disorders Multiple sclerosis, myelitis, facial palsy, polyneuritis such as Guillain-Barré syndrome (with ascending paralysis), optic neuritis General disorders and administration Stinging and burning sensation site conditions Investigations Abnormal liver function tests * refers to adverse reactions observed in clinical trials performed with the paediatric formulation
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-04T10:50:00Z · SHA-256 a6c42f246f9166fd7e859c1877e94342dffe4df1f7128d39d09ec7fe44fefefe · Passage 58c630318b133fb7f341e456b3cc30182e46f22e7d4146736e597d827445d0cd · Zeichen 1370–5023 im Abschnitt